Tag: VEITHsymposium 2023
Haemodialysis access session offers routes to improved outcomes for patients
At the 2023 VEITHsymposium (14–18 November, New York, USA), the final day featured a dedicated programme entitled “Improving outcomes in haemodialysis access”, which was...
Education of patients and parents imperative for the future of paediatric...
“You have to have a balanced approach.” This was the core message from Vincent Rowe (University of California Los Angeles Health, Los Angeles, USA)...
Renal Interventions 10 – US
Highlights
Insights into education surrounding Paediatric dialysis access highlighted by Vincent Rowe (Los Angeles, USA).
Koen van der Bogt (Leiden, The Netherlands) and Joris...
Renal Interventions 10 – EU
Highlights
Insights into education surrounding Paediatric dialysis access highlighted by Vincent Rowe (Los Angeles, USA).
Koen van der Bogt (Leiden, The Netherlands) and Joris...
Phraxis presents trial results and extended study data for EndoForce endovascular...
At this year’s VEITHsymposium (14–18 November, New York, USA), Alexander Yevzlin (Azura Surgery Center, Madison, USA) gave a presentation on the EndoForce endovascular...
Seven key elements for effective compliance for vascular access providers are...
In a recent presentation at the VEITHsymposium 2023 (14–18 November, New York, USA), Terry Litchfield (president, Access Solutions) outlined what she believes to be...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented...
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...